Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Multiple Sclerosis

Free Subscription 09.02.2026 1 Acta Neuropathol 1 Arch Phys Med Rehabil 1 BMC Neurol 1 Brain 1 J Neurol 1 J Neurol Neurosurg Psychiatry 3 J Neurol Sci 2 Mult Scler 1 Neurology 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Neuropathol

1. GIORDANO A, Stridh P, Preziosa P, Pisa M, et al
   A HIF1A variant impacts long-term disability and smoldering inflammation in multiple sclerosis.
   Acta Neuropathol. 2026;151:12.
   PubMed         Abstract available
   
   

   
   Arch Phys Med Rehabil

2. KIM J, Ehde DM, Alschuler KN, Fritz NE, et al
   Daily Temporal Associations Between Use of Psychoactive Substances and Fatigue, Pain, Stress, and Depressive Symptoms in People with Multiple Sclerosis.
   Arch Phys Med Rehabil. 2026 Feb 1:S0003-9993(26)00035.
   PubMed         Abstract available
   
   

   
   BMC Neurol

3. LAPEVANDANI MM, Khodadadi S, Naghitehrani KH, Ayoubi S, et al
   Risk factors affecting the age at onset in adult patients with multiple sclerosis.
   BMC Neurol. 2026 Jan 30. doi: 10.1186/s12883-025-04607.
   PubMed        
   
   

   
   Brain

4. MURARO PA, De Matteis E, Scalfari A
   A tight match: comparing the effectiveness of immune reconstitution therapies for multiple sclerosis.
   Brain. 2026 Feb 3:awag044. doi: 10.1093.
   PubMed        
   
   

   
   J Neurol

5. SOUISSI A, Patti F, Spelman T, Chisari C, et al
   Effect of late-onset on multiple sclerosis phenotype and outcome: evidence from a multi-national registry.
   J Neurol. 2026;273:114.
   PubMed         Abstract available
   
   

   
   J Neurol Neurosurg Psychiatry

6. KACAR S, van Nederpelt DR, Jelgerhuis JR, Coerver EME, et al
   Brain atrophy rates vary with age in relapsing-remitting multiple sclerosis.
   J Neurol Neurosurg Psychiatry. 2026 Feb 4:jnnp-2025-337779.
   PubMed         Abstract available
   
   

   
   J Neurol Sci

7. BAHARNOORI M, Glanz B, Polgar-Turcsanyi M, Saxena S, et al
   Correlation between blood biomarkers and patient-reported outcomes (PROs) of depression and mental health scores in individuals with multiple sclerosis (iwMS).
   J Neurol Sci. 2026;482:125786.
   PubMed         Abstract available
   
   
8. ALBITES COEN B, Chowdhury P, Messina SA, Keegan BM, et al
   Brain MRI to detect cervical spinal cord critical demyelinating lesions in progressive MS.
   J Neurol Sci. 2026;481:125761.
   PubMed         Abstract available
   
   
9. GUIDO FS, Chen JJ, Decker PA, Fereidan-Esfahani M, et al
   The impact of adding optical coherence tomography in MS diagnostic criteria on the classification of tumefactive demyelination.
   J Neurol Sci. 2026;481:125739.
   PubMed         Abstract available
   
   

   
   Mult Scler

10. DI ANTONIO F, Brichetto G, Tacchino A, Pedulla L, et al
    Patient-reported outcomes as predictors of disability evolution in Multiple Sclerosis: An interpretable machine learning approach.
    Mult Scler. 2026 Jan 30:13524585251411093. doi: 10.1177/13524585251411093.
    PubMed         Abstract available
    
    
11. BOLLO L, Pareto D, Tagliani P, Sceppacuercia S, et al
    Optic nerve imaging with OCT predicts disease progression and monitors brain and spinal atrophy in primary progressive multiple sclerosis.
    Mult Scler. 2026 Jan 30:13524585251407976. doi: 10.1177/13524585251407976.
    PubMed         Abstract available
    
    

    
    Neurology

12. VAN NEDERPELT DR, Bos L, Mattiesing RM, Strijbis EM, et al
    Multiple Sclerosis-Specific Reference Curves for Brain Volumes to Explain Disease Severity.
    Neurology. 2026;106:e214694.
    PubMed        
    
    

    
    Proc Natl Acad Sci U S A

13. OLCHANYI MD, Schreier DR, Li J, Maffei C, et al
    Probabilistic mapping and automated segmentation of human brainstem white matter bundles.
    Proc Natl Acad Sci U S A. 2026;123:e2509321123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum